SCHEMBL133336

SCHEMBL133336

CCc1sc(N)c(C(=O)c2ccc(C)cc2)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.50
MAPT P10636 8/20 0.50
LMNA P02545 6/20 0.50
GAA P10253 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
GRM6 O15303 1/20 0.47
HPGD P15428 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
USP2 O75604 1/20 0.44
ALOX15 P16050 1/20 0.44
RECQL P46063 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CNR2 P34972 1/20 0.44
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 1/20 0.42
SRD5A2 P31213 1/20 0.41
RAB9A P51151 2/20 0.40
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1497810 0.88 TDP1 (0.48) ALDH1A1MAPTLMNAGAAGRM6
SCHEMBL135598 0.80 ALDH1A1 (0.75) ALDH1A1MAPTLMNAGAAL3MBTL1
SCHEMBL133651 0.78 ALDH1A1 (0.50) ALDH1A1MAPTLMNAGAAL3MBTL1
SCHEMBL7491114 0.77 TDP1 (0.46) ALDH1A1MAPTLMNAGAAGRM6
SCHEMBL267943 0.76 ALDH1A1 (0.47) ALDH1A1MAPTLMNAGAAGRM6
Hydrochloric Acid SCHEMBL28209357 0.75 ALDH1A1 (0.58) ALDH1A1MAPTLMNAGAAHPGD
SCHEMBL22994585 0.72 ALDH1A1 (0.41) ALDH1A1MAPTLMNAGAAGRM6
SCHEMBL10710308 0.72 ALDH1A1 (0.68) ALDH1A1MAPTLMNAGAAL3MBTL1
SCHEMBL10713052 0.72 ALDH1A1 (0.62) ALDH1A1MAPTLMNAGAAGRM6
SCHEMBL8671592 0.71 MAPT (0.72) ALDH1A1MAPTLMNAGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885MAPT 2061/4885LMNA 3907/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885MAPT 2061/4885LMNA 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.